Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ArtryaASX:AYA +8.80%27 OCF Margin % is -15,995.59% as of Dec. 2025. GuruFocus rates ASX:AYA with a GF Score™ of 27/100. Among 665 Healthcare Providers & Services companies, Artrya ranks worse than 100% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Artrya's Cash Flow from Operations for the
six
months ended in Dec. 2025 was A$-10.88 Mil. Artrya's Revenue for the
six
months ended in Dec. 2025 was A$0.07 Mil. Therefore, Artrya's OCF Margin % for the quarter that ended in Dec. 2025 was -15,995.59%.
The historical rank and industry rank for Artrya's OCF Margin % or its related term are showing as below:
ASX:AYA'
s OCF Margin % Range Over the Past 10 Years
Min: -50967.86 Med: -50967.86 Max: -50967.86
Current: -25402.41
During the past 5 years, the highest OCF Margin % of Artrya was -50967.86%. The lowest was -50967.86%. And the median was -50967.86%.
ASX:AYA's OCF Margin % is ranked worse than 100% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 8.27
vs ASX:AYA: -25402.41
The historical data trend for Artrya's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AYA vs VEEV, BTSG, HQY: OCF Margin % Comparison
For the Health Information Services subindustry, Artrya's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artrya OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artrya's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Artrya's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artrya (ASX:AYA) has a OCF Margin % of -15,995.59% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Artrya and its competitors. According to the industry distribution chart, Artrya ranks #665 out of 665 companies in the Healthcare Providers & Services industry.
Is Artrya's OCF Margin % too high?
Artrya's current OCF Margin % is -15,995.59%. Based on the distribution chart, Artrya ranks #665 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artrya has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Artrya's OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Artrya ranks #665 out of 665 companies for OCF Margin %. This places Artrya in the lower half of its industry. The industry median OCF Margin % is 8.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Artrya and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artrya's current OCF Margin % is -15,995.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artrya stock overvalued right now?
Artrya (ASX:AYA) has a current OCF Margin % of -15,995.59%. The current OCF Margin % is -15,995.59%. Artrya's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Artrya (ASX:AYA), the current OCF Margin % is -15,995.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
27GF Score
Get the complete analysis for ASX:AYA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AYA has been successfully added to your 
